// App-Quantinova.ai

3575 : Prognostic utility of the presence of extramural vascular invasion in stage II and III colorectal cancer: data from the FACS randomised controlled trial.

Researchers

Presenter

  • Sian Alexandra Pugh

Principal Investigators

  • David Mant

  • Nicholas Mark Jenkins

  • Alexander H Mirnezami

  • Adrian C Bateman

  • Tim Iveson

  • Bethany Shinkins

  • John Neil Primrose

Medical Centers

  • Southampton University Hospitals NHS Trust, Southhampton, United Kingdom

  • University of Oxford, Oxford, United Kingdom

  • Hampshire Hospitals Foundation Trust, Winchester, United Kingdom

  • Cancer Sciences, University of Southampton, Southampton, United Kingdom

  • Southampton General Hospital, Southampton, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • Leeds Institute of Health Sciences, Leeds, United Kingdom

  • University of Southampton, Southampten, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • Carcinoembryonic antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Observational

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved